Patrick Daly

DocwireNews

The approvals of the 7-valent pneumococcal conjugate vaccine (PCV7) and the 13-valent PCV (PCV13) in 2000 and 2010, respectively, significantly reduced the rate of invasive pneumococcal infection (IPD) in children with <a href="https://www.docwirenews.com/page/sickle-cell-disease">sickle cell disease</a> (SCD). The more recent 23-valent pneumococcal polysaccharide vaccine (PPSV23) and 15-, 20-, and 21-valent PCVs (PCV15, PCV20, PCV21) provide protection against 62%, 16%, 51%, and 92% additional IPD serotypes compared with PCV13, respectively.According to a study, led by Thomas Adamkiewicz, over a span of 25 years, the Georgia Emerging Infections Program and Centers for Disease Control and Prevention Active Bacterial Core surveillance network recorded 104 cases of IPD in 3707 children aged &lt;10 years with hemoglobin SS or hemoglobin SC, representing 6% of IPD in Black or African American children in a metropolitan Atlanta reference population. Adamkiewicz noted children with IPD and hemoglobin SS or SC were older compared with children with only IPD in the reference group (P&lt;.001).<h2>Outcomes Improve but IPD Potentially More Common in SCD</h2>Investigators reported that IPD declined by 87% and 80% in children with hemoglobin SS aged 0-4 and 5-9 years, respectively, between the periods of 1994-1999 and 2010-2018. However, the incidence rate ratio of IPD between children with SCD and the reference population increased from 20.2 to 29.2 in the same period. That said, after 2002, children with hemoglobin SS and IPD had a decline in mortality rate from 14% to 3% and meningitis from 16% to 8%. Additionally, resistance to penicillin was more common in children with SCD prior to the approval of PCV7.The effectiveness of PPSV23 plus 15A/15C against IPD serotypes not covered by <a href="https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert------Prevnar-13.pdf">PCV13</a> within 3 years of vaccination was 92% (95% CI, 40.8-99.0;&nbsp;P=.014), adjusted for age and hydroxyurea. Further, PCV15, PCV20, and the in-development PCV21/V116 could cover 16%, 51%, and 92%, respectively, of non-PCV13 serotype IPD in children with SCD.Overall, Adamkiewicz and colleagues suggested that &ldquo;although less frequent, IPD remains a life-threatening risk in children with SCD. Effective vaccines with broader coverage could benefit these children.&rdquo;&nbsp;Related: <a href="https://www.docwirenews.com/post/stem-cell-gene-therapy-shows-promise-as-treatment-for-sickle-cell-disease">Stem Cell Gene Therapy Shows Promise as Treatment for Sickle Cell Disease</a>

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Hatem Soliman, MD

Using Dendritic Cell Vaccines to Boost Neoadjuvant Therapy in HER2+ Breast Cancer

HER2 Breast Cancer

Kathleen Liu, MD

Joel M. Topf, MD, FACP

AKI Approaches and ASN Kidney Health Guidance

NKF Spring Clinical Meetings 2025

Latest News

Characterizing Infections in Children With Sickle Cell Disease Over Time

Sickle Cell Disease

Researchers characterized the historical effect of pneumococcal conjugate vaccine developments on pneumococcal infections in children with sickle cell disease.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe